Intellectual Property
To date, Oculus has been issued 11 patents for the Microcyn Technology. As well, there are 88 patents pending. Since 1995, the patent term in the United States is 20 years from the earliest claimed filing date. Our issued U.S. patent was filed on September 13, 2002.  As well, there are 33 patents pending; 13 in the United States and 20 foreign.

Oculus’ patent claims include chemical composition, manufacturing apparatus, method of manufacturing and therapeutic uses. While the Microcyn Technology has been commercialized globally for the past three years, there have been no infringement lawsuits filed against the company. 

Oculus recently prevailed in a favorable Federal Court ruling against a company that had infringed upon Oculus’ intellectual property.